<p>Hinge Health Inc.（纽约证券交易所代码：HNGE - 获取免费报告）的股票在周五交易中下跌了 8.6%。该股最低交易价格为 37.15 美元，最后交易价格为 36.7050 美元。在午盘交易中，约有 698,009 股易手，较日均交易量 1,263,011 股下降了 45%。该股此前收盘价为 40.18 美元。</p>
<h2>分析师评级变动</h2>
<ul>
<li>MarketBeat 周报 – 02/23 - 02/27</li>
</ul>
<p>几位研究分析师对该股票发表了评论。Needham &amp; Company LLC 在 2 月 11 日的报告中重申了对 Hinge Health 的 “买入” 评级，并设定了 59.00 美元的目标价。Weiss Ratings 在 1 月 22 日的研究报告中重申了对 Hinge Health 的 “卖出（d）” 评级。加拿大皇家银行在 3 月 11 日的研究报告中将 Hinge Health 的目标价从 50.00 美元上调至 55.00 美元，并给予该公司 “跑赢大盘” 的评级。Citizens Jmp 在 2 月 11 日的研究报告中重申了 “市场跑赢大盘” 的评级，并对 Hinge Health 设定了 65.00 美元的目标价。最后，Canaccord Genuity Group 在 2 月 11 日的报告中将 Hinge Health 的目标价从 65.00 美元下调至 53.00 美元，并对该股票设定了 “买入” 评级。一位投资分析师给予该股票 “强烈买入” 评级，十六位分析师给予 “买入” 评级，一位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，Hinge Health 目前的平均评级为 “适度买入”，平均目标价为 57.07 美元。</p>
<p><strong>阅读我们对 HNGE 的最新分析</strong></p>
<h2>Hinge Health 股票表现</h2>
<ul>
<li>Hinge Health 的 AI 护城河可能是其患者运动数据</li>
</ul>
<p>该公司的 50 日移动平均价格为 40.71 美元，200 日移动平均价格为 46.37 美元。该股市值为 28.8 亿美元，市盈率为-2.86。</p>
<p>Hinge Health（纽约证券交易所代码：HNGE - 获取免费报告）最近在 2 月 10 日公布了季度财报。该公司报告季度每股收益为 0.49 美元，超出分析师共识预期的 0.04 美元，超出幅度为 0.45 美元。该季度的营业收入为 1.7073 亿美元，而共识预期为 1.5731 亿美元。该公司的季度收入同比增长了 45.5%。</p>
<h2>内部买卖</h2>
<ul>
<li>突出新兴公司：这些 2025 年 IPO 主导了这一年</li>
</ul>
<p>在其他新闻中，总裁 James Pursley 在 3 月 23 日的交易中出售了 15,000 股公司的股票。该股票以平均价格 42.26 美元出售，总交易额为 633,900.00 美元。交易后，总裁持有 732,104 股公司股票，估值约为 30,938,715.04 美元。此次交易使其持股减少了 2.01%。该交易已在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。此外，首席执行官 Daniel Antonio Perez 在 2 月 12 日的交易中出售了 166,665 股该股票。该股票以平均价格 40.26 美元出售，总价值为 6,709,932.90 美元。此次出售的披露信息可在 SEC 文件中找到。内部人士在上个季度出售了 526,002 股公司股票，估值为 23,092,172 美元。</p>
<h2>机构资金流入和流出</h2>
<p>几家机构投资者和对冲基金最近买卖了 HNGE 的股票。富国银行（Wells Fargo &amp; Company MN）在第四季度将其在 Hinge Health 的股份增加了 160.0%。富国银行目前持有 546 股公司股票，估值为 25,000 美元，此前在该期间内增持了 336 股。凯通国际资产管理有限公司（Caitong International Asset Management Co. Ltd）在第四季度购买了 Hinge Health 的新头寸，价值约为 26,000 美元。未来资产全球投资有限公司（Mirae Asset Global Investments Co. Ltd.）在第三季度购买了 Hinge Health 的新头寸，价值约为 37,000 美元。第一地平线公司（First Horizon Corp）在第四季度将其在 Hinge Health 的股份增加了 163.9%。第一地平线公司目前持有 855 股公司股票，价值 40,000 美元，此前在该期间内增持了 531 股。最后，高点财富管理有限公司（High Point Wealth Management LLC）在第四季度购买了 Hinge Health 的新股份，价值约为 46,000 美元。</p>
<h2>Hinge Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Hinge Health（纽约证券交易所代码：HNGE）是一家数字肌肉骨骼（MSK）诊所，提供肌肉骨骼疾病的预防和管理的端到端解决方案。该公司的平台结合了可穿戴运动传感器、由持证物理治疗师指导的个性化运动疗法和行为健康辅导，以提供量身定制的治疗方案。通过将技术与循证临床协议相结合，Hinge Health 旨在减轻疼痛、改善活动能力，并减少对更具侵入性干预措施（如手术或阿片类药物处方）的依赖。</p>
<p>Hinge Health 成立于 2015 年，总部位于旧金山，与雇主、健康计划和其他支付方合作，提供其自我指导的应用程序基础项目。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，而不是 Hinge Health</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Hinge Health 吗？</h2>
<p>在你考虑 Hinge Health 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 Hinge Health 并不在名单上。</p>
<p>虽然 Hinge Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美国医疗保健供应商 ETF - iShares

HNGE

标普健康医疗设备 ETF - SPDR

标普医疗保健服务 ETF - SPDR

美国医药设备 ETF - iShares

<p>Hinge Health（纽约证券交易所代码：HNGE）股价下跌 8.6%，至 36.7050 美元，交易量较平均水平下降 45%。分析师的评级意见不一：Needham 维持 “买入” 评级，目标价为 59 美元，而 Weiss Ratings 则建议 “卖出”。该股票的市值为 28.8 亿美元，季度每股收益为 0.49 美元，超出预期。内部人士的卖出包括总裁 James Pursley 和首席执行官 Daniel Antonio Perez 的大量股份。机构投资者也表现活跃，富国银行等的持股比例显著增加。Hinge Health 专注于数字肌肉骨骼解决方案</p>

<p>Shares of Hinge Health Inc. (NYSE:HNGE - Get Free Report) dropped 8.6% during trading on Friday . The stock traded as low as $37.15 and last traded at $36.7050. Approximately 698,009 shares changed hands during mid-day trading, a decline of 45% from the average daily volume of 1,263,011 shares. The stock had previously closed at $40.18.</p>
<div class="lb-trans"><p>Hinge Health Inc.（纽约证券交易所代码：HNGE - 获取免费报告）的股票在周五交易中下跌了 8.6%。该股最低交易价格为 37.15 美元，最后交易价格为 36.7050 美元。在午盘交易中，约有 698,009 股易手，较日均交易量 1,263,011 股下降了 45%。该股此前收盘价为 40.18 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><ul>
<li>MarketBeat Week in Review – 02/23 - 02/27</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 02/23 - 02/27</li>
</ul>
</div><p>Several research analysts have commented on the stock. Needham &amp; Company LLC reissued a &#34;buy&#34; rating and set a $59.00 price objective on shares of Hinge Health in a report on Wednesday, February 11th. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Hinge Health in a research report on Thursday, January 22nd. Royal Bank Of Canada increased their price target on Hinge Health from $50.00 to $55.00 and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, March 11th. Citizens Jmp reaffirmed a &#34;market outperform&#34; rating and issued a $65.00 price objective on shares of Hinge Health in a research note on Wednesday, February 11th. Finally, Canaccord Genuity Group decreased their price objective on Hinge Health from $65.00 to $53.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Hinge Health presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $57.07.</p>
<div class="lb-trans"><p>几位研究分析师对该股票发表了评论。Needham &amp; Company LLC 在 2 月 11 日的报告中重申了对 Hinge Health 的 “买入” 评级，并设定了 59.00 美元的目标价。Weiss Ratings 在 1 月 22 日的研究报告中重申了对 Hinge Health 的 “卖出（d）” 评级。加拿大皇家银行在 3 月 11 日的研究报告中将 Hinge Health 的目标价从 50.00 美元上调至 55.00 美元，并给予该公司 “跑赢大盘” 的评级。Citizens Jmp 在 2 月 11 日的研究报告中重申了 “市场跑赢大盘” 的评级，并对 Hinge Health 设定了 65.00 美元的目标价。最后，Canaccord Genuity Group 在 2 月 11 日的报告中将 Hinge Health 的目标价从 65.00 美元下调至 53.00 美元，并对该股票设定了 “买入” 评级。一位投资分析师给予该股票 “强烈买入” 评级，十六位分析师给予 “买入” 评级，一位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat 的数据，Hinge Health 目前的平均评级为 “适度买入”，平均目标价为 57.07 美元。</p>
</div><p><strong>Read Our Latest Analysis on HNGE</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 HNGE 的最新分析</strong></p>
</div><h2>Hinge Health Stock Performance</h2>
<div class="lb-trans"><h2>Hinge Health 股票表现</h2>
</div><ul>
<li>Hinge Health’s AI Moat Might Be Its Patient Movement Data</li>
</ul>
<div class="lb-trans"><ul>
<li>Hinge Health 的 AI 护城河可能是其患者运动数据</li>
</ul>
</div><p>The business's fifty day moving average price is $40.71 and its two-hundred day moving average price is $46.37. The stock has a market capitalization of $2.88 billion and a P/E ratio of -2.86.</p>
<div class="lb-trans"><p>该公司的 50 日移动平均价格为 40.71 美元，200 日移动平均价格为 46.37 美元。该股市值为 28.8 亿美元，市盈率为-2.86。</p>
</div><p>Hinge Health (NYSE:HNGE - Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.45. The business had revenue of $170.73 million during the quarter, compared to the consensus estimate of $157.31 million. The firm's revenue for the quarter was up 45.5% on a year-over-year basis.</p>
<div class="lb-trans"><p>Hinge Health（纽约证券交易所代码：HNGE - 获取免费报告）最近在 2 月 10 日公布了季度财报。该公司报告季度每股收益为 0.49 美元，超出分析师共识预期的 0.04 美元，超出幅度为 0.45 美元。该季度的营业收入为 1.7073 亿美元，而共识预期为 1.5731 亿美元。该公司的季度收入同比增长了 45.5%。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><ul>
<li>Notable Newcomers: These 2025 IPOs Dominated the Year</li>
</ul>
<div class="lb-trans"><ul>
<li>突出新兴公司：这些 2025 年 IPO 主导了这一年</li>
</ul>
</div><p>In other news, President James Pursley sold 15,000 shares of the business's stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average price of $42.26, for a total transaction of $633,900.00. Following the transaction, the president owned 732,104 shares of the company's stock, valued at approximately $30,938,715.04. The trade was a 2.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Daniel Antonio Perez sold 166,665 shares of the stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $40.26, for a total value of $6,709,932.90. The disclosure for this sale is available in the SEC filing. Insiders sold 526,002 shares of company stock valued at $23,092,172 over the last quarter.</p>
<div class="lb-trans"><p>在其他新闻中，总裁 James Pursley 在 3 月 23 日的交易中出售了 15,000 股公司的股票。该股票以平均价格 42.26 美元出售，总交易额为 633,900.00 美元。交易后，总裁持有 732,104 股公司股票，估值约为 30,938,715.04 美元。此次交易使其持股减少了 2.01%。该交易已在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。此外，首席执行官 Daniel Antonio Perez 在 2 月 12 日的交易中出售了 166,665 股该股票。该股票以平均价格 40.26 美元出售，总价值为 6,709,932.90 美元。此次出售的披露信息可在 SEC 文件中找到。内部人士在上个季度出售了 526,002 股公司股票，估值为 23,092,172 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several institutional investors and hedge funds have recently bought and sold shares of HNGE. Wells Fargo &amp; Company MN raised its stake in shares of Hinge Health by 160.0% in the fourth quarter. Wells Fargo &amp; Company MN now owns 546 shares of the company's stock valued at $25,000 after acquiring an additional 336 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in shares of Hinge Health during the 4th quarter worth about $26,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Hinge Health during the 3rd quarter valued at about $37,000. First Horizon Corp raised its position in Hinge Health by 163.9% in the 4th quarter. First Horizon Corp now owns 855 shares of the company's stock worth $40,000 after purchasing an additional 531 shares during the period. Finally, High Point Wealth Management LLC purchased a new stake in Hinge Health in the 4th quarter worth about $46,000.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近买卖了 HNGE 的股票。富国银行（Wells Fargo &amp; Company MN）在第四季度将其在 Hinge Health 的股份增加了 160.0%。富国银行目前持有 546 股公司股票，估值为 25,000 美元，此前在该期间内增持了 336 股。凯通国际资产管理有限公司（Caitong International Asset Management Co. Ltd）在第四季度购买了 Hinge Health 的新头寸，价值约为 26,000 美元。未来资产全球投资有限公司（Mirae Asset Global Investments Co. Ltd.）在第三季度购买了 Hinge Health 的新头寸，价值约为 37,000 美元。第一地平线公司（First Horizon Corp）在第四季度将其在 Hinge Health 的股份增加了 163.9%。第一地平线公司目前持有 855 股公司股票，价值 40,000 美元，此前在该期间内增持了 531 股。最后，高点财富管理有限公司（High Point Wealth Management LLC）在第四季度购买了 Hinge Health 的新股份，价值约为 46,000 美元。</p>
</div><h2>Hinge Health Company Profile</h2>
<div class="lb-trans"><h2>Hinge Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.</p>
<div class="lb-trans"><p>Hinge Health（纽约证券交易所代码：HNGE）是一家数字肌肉骨骼（MSK）诊所，提供肌肉骨骼疾病的预防和管理的端到端解决方案。该公司的平台结合了可穿戴运动传感器、由持证物理治疗师指导的个性化运动疗法和行为健康辅导，以提供量身定制的治疗方案。通过将技术与循证临床协议相结合，Hinge Health 旨在减轻疼痛、改善活动能力，并减少对更具侵入性干预措施（如手术或阿片类药物处方）的依赖。</p>
</div><p>Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.</p>
<div class="lb-trans"><p>Hinge Health 成立于 2015 年，总部位于旧金山，与雇主、健康计划和其他支付方合作，提供其自我指导的应用程序基础项目。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Hinge Health</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 Hinge Health</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Hinge Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Hinge Health 吗？</h2>
</div><p>Before you consider Hinge Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Hinge Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 Hinge Health 并不在名单上。</p>
</div><p>While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Hinge Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Hinge Health (NYSE:HNGE) 股价下跌 8.6% - 现在是卖出的时候吗？